NeoMed is excited to announce a partnership with Medima Sp to provide a complete enteral nutrition delivery solution for NICUs and PICUs across Europe, parts of Asia, and the Middle East. This innovative nutrition delivery system enables neonatal and pediatric clinicians to deliver enteral feeds managed by the Medima S100 and S200 pumps' advanced features combined with NeoMed's NeoConnect® devices. Compared to other manual delivery methods, NeoMed’s Enteral Library supports customized feeding protocols from volumes of 1 mL per hour to high volume bolus feeds, and continuous feeds at varying time intervals. The cost-effective Medima S100 and S200 pumps include a clamp, two-year limited warranty, and extended service options.
Clinicians may use the Medima S100 and S200 pumps to deliver modular compounded nutrition that may be difficult to deliver via gravity feeding. The NeoMed and Medima solution provides an effective option for the delivery of viscous compounded breastmilk formulations. Unlike gravity feeding, pump feeding helps facilitate closed system administration in accordance with clinical guidelines for care of immunocompromised patients.
The Medima S100 and S200 pump models feature many benefits and capabilities including safe and precise delivery, custom volume-over-time enteral delivery options, automatic recall, an intuitive and user-friendly interface, comprehensive configuration options, and much more. When used with the NeoMed Enteral Library, the pump’s purple color display visually indicates enteral administration. The portfolio of pump-validated NeoConnect® syringes includes sizes 6 mL – 60 mL. NeoConnect syringes feature an offset tip, which promotes lipid-first delivery while eliminating the need to tilt the pump vertically.
Vice President of International Operations, Hilary Sherman, stated “Partnering with Medima to offer a comprehensive enteral nutrition delivery system will advance the use of closed system administration feeding methods while enhancing compounded nutrition efficacy and patient outcomes in NICUs and PICUs across Europe.”
For more information contact your NeoMed Account Manager, visit www.neomedimv.eu, or call 353 087 051 8901.
About NeoMed, Inc.
Founded in 2007, NeoMed develops innovative enteral collection and delivery products supporting the specialized feeding and medication dosing needs of the low birth weight, neonatal, and pediatric patients. With over 250 successful ENFit transitions representing over 24 million administered feed and medication doses, NeoMed is committed to improve patient outcomes through product designs that meet safety, clinical, and regulatory guidelines while supporting cost-containment objectives.
NM-1122 Rev 1